By Amina Niasse NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health on Thursday began offering a much ...

By comparison, Novo Nordisk’s Wegovy pill—launched earlier this year and already used by more than 170,000 people, CEO Mike ...

Hims & Hers Health, Eli Lilly, and Novo Nordisk shares all slid Thursday after Hims & Hers said it would start selling a ...

We’ve all heard of Ozempic by now. It’s only licensed for use as a diabetes treatment in the UK and US, but it's widely used ‘off label’ to help people lose weight. So much so, in fact, that its name ...

Hims & Hers' gambit to sell a $49 compounded version of Novo Nordisk's Wegovy pill is rattling obesity shares, sparking ...

US telehealth group Hims & Hers has launched a cheaper version of Novo Nordisk’s Wegovy pill to retail at $49 per month, ...

Demand for Novo Nordisk's Weight Loss Pill Is Strong Out of the Gate. Is the Stock Due for a Big Rally? Novo Nordisk's weight ...

How does the new Wegovy pill compare to the shot for weight loss? Here are six ways, from side effects to absorption.

Wegovy pills are now available in the U.S., offering a prescription-based, convenient alternative for weight management ...

The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.

Novo’s shares plunged after telehealth firm Hims & Hers Health Inc. launched a cheaper copycat version of its Wegovy pill.

A woman among the first in America to take the new Wegovy pill has claimed that she is yet to have any side effects. Sharon ...